AIN: Shorts Retreat Ahead of Thursday Earnings

Albany International Corp. heads into its Q1 2026 earnings call on April 30 with short sellers firmly in retreat — the clearest positioning signal going into the print.

Short sellers have been cutting exposure at a rapid clip. SI as a percentage of the free float has dropped to 1.8%, nearly halved from levels above 2.2% seen in mid-March. Over the past month alone, estimated short positions fell almost 19%. The sharpest move came in early April, when SI briefly climbed toward 2.1% during the broad market dislocation, then collapsed — shrinking another 7% in a single session on April 28. Days to cover have compressed to under three days per the latest FINRA-reported data, leaving little structural overhang. In the lending market, availability is exceptionally loose: borrowing costs are running at 0.45%, down nearly 14% on the week, and the borrow pool is almost entirely untapped. That combination — falling SI, cheap borrow, ample availability — points to a market where bears have been taking chips off the table, not adding.

The options market tells a notably different story. Put-to-call ratios on AIN are running at 7.8, far above the 52-week low of 0.11 reached in early April. The PCR collapsed sharply from an extreme of around 16-17 in the first week of April, which coincided with the market volatility peak, and has since settled at a structurally elevated level. The z-score against the 20-day average is essentially flat at -0.12, meaning the current read is roughly in line with the recent norm — but that norm is itself skewed heavily toward puts. This is a thinly traded options market, and the PCR can reflect positioning rather than directional conviction, but the persistent put-heaviness deserves a note.

The Street has gone quiet on AIN. The most recent analyst actions on record are from January 2026 — JP Morgan's Stephen Tusa nudged his target to $47 while keeping a Neutral rating — and that data point is now over three months old. Earlier actions from mid-to-late 2025 told a consistent downgrade story: Truist and Baird both moved to Hold/Neutral, and Bank of America retained its Underperform through multiple target cuts. The mean consensus target at last count sat at $56.25, marginally above the current price of $55.10. With analyst data stale and the stock up 8.4% over the past month, the target has drifted from meaningful upside to something close to parity. Valuation multiples are modest: PE is at 20.4x and EV/EBITDA at 9.0x, both drifting slightly lower over the past week. The ORTEX short score of 30.3 places AIN in the lower third of short-interest pressure readings, consistent with the retreating SI narrative.

Institutional holders are broadly stable. BlackRock and Vanguard together control over 26% of shares, and both added modestly in Q1 2026. American Century was the most active buyer, adding 385,000 shares in the quarter to lift its stake to nearly 5%. On the insider side, recent activity from February was dominated by routine equity award grants accompanied by small tax-withholding sells — nothing that reads as directional conviction either way. The net insider position over the past 90 days is a modest positive in share terms, driven almost entirely by the award cycle.

The last earnings print on February 24 produced a -1.8% one-day move followed by a modest recovery of roughly 1.2% over the following five days — a contained reaction, not a gap. The April 24 event in the history data shows a negligible -0.7% move, likely a non-fundamental catalyst. Among close peers this week, ASTE rallied more than 5% while CR and KAI both fell around 4%, suggesting the industrial machinery group is trading without a coherent directional theme heading into the session. With shorts already reduced, the borrow market loose, and options structurally put-heavy, what tomorrow's Q1 call says about aerospace and machine-clothing segment margins will be the real variable to watch.